AIM ImmunoTech (AIM) Work In Process (2010 - 2015)

AIM ImmunoTech's (AIM) quarterly Work In Process came in at $1.3 million in Q4 2015, little changed on a QoQ basis from $1.3 million in Q3 2015.

AIM ImmunoTech (AIM) Work In Process (2010 - 2015) Analysis & Trends

AIM ImmunoTech (AIM) has 5 years of Work In Process data on file, last reported at $1.3 million in Q4 2015.

Quarterly Work In Process changed N/A year-over-year to $1.3 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $1.3 million (changed N/A YoY) and the FY2015 annual result came in at $1.3 million, changed N/A from the prior year.
Work In Process was little changed at $1.3 million in Q4 2015, from $1.3 million in the prior quarter.
In the past five years, Work In Process ranged from a high of $1.3 million in Q3 2015 to a low of $453000.0 in Q4 2012.
A 4-year average of $917750.0 and a median of $987500.0 in 2011 frame the typical range for Work In Process.
Annual changes were most pronounced in 2012 — Work In Process increased 14.6% — and 2013, when it tumbled 59.12%.
Tracing AIM's Work In Process over 4 years: stood at $897000.0 in 2011, then sank by 49.5% to $453000.0 in 2012, then changed by 0.0% to $453000.0 in 2013, then soared by 192.72% to $1.3 million in 2015.
The last three Work In Process figures came in at $1.3 million (Q4 2015), $1.3 million (Q3 2015), and $1.0 million (Q2 2015), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.88 Bn	132.03 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.62 Bn	78.62 Bn	3.93 Bn
3	Argenx Se	65.28 Bn	60.10 Bn	1.37 Bn
4	Moderna	61.39 Bn	56.25 Bn	52.00 Mn
5	BeOne Medicines	42.11 Bn	37.01 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.37 Bn	28.06 Bn	992.69 Mn
7	BioNTech SE	28.76 Bn	10.37 Bn	668.28 Mn
8	Insmed	27.46 Bn	26.30 Bn	358.27 Mn
9	Royalty Pharma	27.24 Bn	26.41 Bn	-
10	AIM ImmunoTech	4.40 Mn	-5.56 Mn	21,000.00

Download Data